Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

5.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.3K
Clinical Trials01:16

Clinical Trials

11.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.1K
Preclinical Development: Overview01:28

Preclinical Development: Overview

6.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.3K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

201
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
201
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

280
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
280
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

441
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
441

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protocol for a SPIRIT extension for reporting Pragmatic and Explanatory trial protocols designed using the PRECIS tool. (SPIRIT-PRECIS).

Journal of clinical epidemiology·2026
Same author

SPIRIT 2025 statement: updated guideline for protocols of randomised trials.

Lancet (London, England)·2026
Same author

SPIRIT-Children and Adolescents (SPIRIT-C) 2026 extension statement: enhancing the reporting and usefulness of paediatric randomised trial protocols.

The Lancet. Child & adolescent health·2026
Same author

CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of paediatric randomised trials.

The Lancet. Child & adolescent health·2026
Same author

Reporting of Cohort and Routinely Collected Data in Randomised Controlled Trial Protocols (SPIRIT-ROUTINE): extension checklist with explanation and elaboration.

BMJ (Clinical research ed.)·2026
Same author

Author adherence and experiences with PRISMA-P 2015: a cross-sectional study.

Journal of clinical epidemiology·2026
Same journal

[Comparing taxes as a percentage of sugar-sweetened beverage prices in Latin America and the CaribbeanComparação dos impostos como uma porcentagem do preço das bebidas açucaradas na América Latina e no Caribe].

Revista panamericana de salud publica = Pan American journal of public health·2026
Same journal

[Prevalence of HTLV-1 infection in family members of index cases in PeruPrevalência familiar da infecção pelo HTLV-1 a partir de um caso índice no Peru].

Revista panamericana de salud publica = Pan American journal of public health·2026
Same journal

The role of regulatory policies on unhealthy commodities to prevent and control noncommunicable diseases in the Americas.

Revista panamericana de salud publica = Pan American journal of public health·2026
Same journal

[An overview of home care for patients with chronic diseases in Latin America: A scoping reviewPanorama da atenção domiciliar para pacientes com doenças crônicas na América Latina: revisão de escopo].

Revista panamericana de salud publica = Pan American journal of public health·2026
Same journal

[Glycemic control, psychosocial factors, and quality of life among people with diabetes in primary health care settingsControl de la glucemia, factores psicosociales y calidad de vida en personas con diabetes en entornos de atención primaria de salud].

Revista panamericana de salud publica = Pan American journal of public health·2026
Same journal

[Commercially available complementary foods in Argentina and Mexico: An analysis of their nutritional composition, labeling, and promotionAlimentos complementares comercializados na Argentina e no México: análise da composição nutricional, rotulagem e promoção].

Revista panamericana de salud publica = Pan American journal of public health·2026
See all related articles

Related Experiment Video

Updated: Mar 17, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K

SPIRIT 2013 Statement: defining standard protocol items for clinical trials.

An-Wen Chan1, Jennifer M Tetzlaff2, Douglas G Altman3

  • 1Women's College Research Institute Women's College Hospital.

Revista Panamericana De Salud Publica = Pan American Journal of Public Health
|July 22, 2016
PubMed
Summary
This summary is machine-generated.

The SPIRIT 2013 checklist provides a minimum standard for clinical trial protocol content. Adherence improves protocol quality, transparency, and completeness for all stakeholders.

More Related Videos

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

18.7K
Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

10.4K

Related Experiment Videos

Last Updated: Mar 17, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

18.7K
Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

10.4K

Area of Science:

  • Clinical Trial Methodology
  • Research Protocol Development

Background:

  • Clinical trial protocols are essential for study planning, conduct, and reporting.
  • Existing protocol guidelines exhibit significant variability in content and quality.

Purpose of the Study:

  • To describe the systematic development and scope of the SPIRIT 2013 guideline.
  • To provide a minimum content standard for interventional clinical trial protocols.

Main Methods:

  • Development of the SPIRIT 2013 guideline through a systematic process.
  • Creation of a 33-item checklist for clinical trial protocol content.

Main Results:

  • The SPIRIT 2013 checklist outlines the minimum required content for clinical trial protocols.
  • The checklist focuses on content, not format, recommending a full description of planned elements.

Conclusions:

  • The SPIRIT recommendations aim to facilitate the drafting of high-quality clinical trial protocols.
  • Adherence to SPIRIT enhances protocol transparency and completeness for diverse stakeholders.